Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Lissy, de Ridder"'
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
In children with gastrointestinal disorders such as inflammatory bowel disease (IBD) and intestinal failure (IF), the risk of venous thromboembolism (VTE) is increased. VTE may lead to pulmonary embolism, sepsis and central line infection, stroke and
Externí odkaz:
https://doaj.org/article/29b1dcb4b8fa418885223c34d2693230
Autor:
Franco Torrente, Susanna Meade, Eric I Benchimol, Lissy de Ridder, Nicholas M Croft, Jochen Kammermeier, David R Mack, Renz C W Klomberg, Dan Turner, David C Wilson, Javier Martín-de-Carpi, Jiri Bronsky, Jorge Amil Dias, Gregor Walker, C Heleen van Ommen, Michael P Powar, Natasha Burgess, Peter M Irving, Mark A Samaan, Richard Hansen
Publikováno v:
Journal of Crohn's & colitis, 16(10), 1609-1616. Oxford University Press
JOURNAL OF CROHNS & COLITIS
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
JOURNAL OF CROHNS & COLITIS
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Background and Aims Thromboprophylaxis use in paediatric inflammatory bowel disease [IBD] is inconsistent. Current guidelines only support treating children with acute severe colitis with risk factors. We convened an international RAND panel to explo
Autor:
Anat Yerushalmy-Feler, Christine Olbjorn, Kaija-Leena Kolho, Marina Aloi, Francesca Musto, Javier Martin-de-Carpi, Ana Lozano-Ruf, Dotan Yogev, Manar Matar, Luca Scarallo, Matteo Bramuzzo, Lissy de Ridder, Ben Kang, Christoph Norden, David C Wilson, Christos Tzivinikos, Dan Turner, Shlomi Cohen
Publikováno v:
Inflammatory Bowel Diseases.
Background Current data on dual biologic therapy in children are limited. This multicenter study aimed to evaluate the effectiveness and safety of dual therapy in pediatric patients with inflammatory bowel disease (IBD). Methods A retrospective study
Autor:
Oren Ledder, Jérôme Viala, Daniela Elena Serban, Darja Urlep, Lissy De Ridder, Massimo Martinelli, Claudio Romano, Peter Church, Chris Griffiths, Salvatore Oliva, Dharam Basude, Shishu Sharma, Mike Thomson
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition.
Autor:
Maria M E Jongsma, Lea M M Costes, Irma Tindemans, Martinus A Cozijnsen, Rolien (H) C Raatgreep, Merel van Pieterson, Yunlei Li, Johanna C Escher, Lissy de Ridder, Janneke N Samsom
Publikováno v:
Journal of Crohn's and Colitis.
Background Despite its efficacy, rational guidance for starting/stopping first-line biologic treatment in individual paediatric Crohn’s disease [CD] patients is needed. We assessed how serum immune profiles before and after first-line infliximab [F
Autor:
Nicholas M Croft, Lissy de Ridder, Anne M Griffiths, Jeffrey S Hyams, Frank M Ruemmele, Dan Turner, Katharine Cheng, Irja Lutsar, Marco Greco, Zuzanna Gołębiewska, Floriane Laumond, Maria Cavaller-Bellaubi, Adam Elgreey, Tara A Altepeter, Chrissi Pallidis, Koen Norga, Robert Nelson, Wallace Crandall, Gilles Vassal
Publikováno v:
Journal of Crohn's & colitis, 17(2), 249-258. Oxford University Press
Background and Aims Despite recent approvals for new drugs to treat adults with Crohn’s disease or ulcerative colitis, there are only two approved advanced treatment options [infliximab and adalimumab] for children with inflammatory bowel disease [
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2933fe299ef362ab1142f48b39899f72
https://pure.eur.nl/en/publications/557fd4fd-0e74-4060-9c04-8b295ed80eae
https://pure.eur.nl/en/publications/557fd4fd-0e74-4060-9c04-8b295ed80eae
Autor:
Luis Menchén, Joana Torres, Monika Tripathi, Nurulamin M Noor, Magali Svrcek, Vincenzo Villanacci, Nina Zidar, Roger Feakins, Triana Lobaton, Paula Borralho-Nunes, Lissy de Ridder, Tiago Cúrdia Gonçalves, Johan Burisch, Ann Driessen, Aart Mookhoek
Publikováno v:
Journal of Crohn's and colitis
Feakins, R, Torres, J, Borralho-Nunes, P, Burisch, J, Cúrdia Gonçalves, T, de Ridder, L, Driessen, A, Lobatón, T, Menchén, L, Mookhoek, A, Noor, N, Svrcek, M, Villanacci, V, Zidar, N & Tripathi, M 2022, ' ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease ', Journal of Crohn's & colitis, vol. 16, no. 3, pp. 343-368 . https://doi.org/10.1093/ecco-jcc/jjab141
Feakins, R, Torres, J, Borralho-Nunes, P, Burisch, J, Cúrdia Gonçalves, T, de Ridder, L, Driessen, A, Lobatón, T, Menchén, L, Mookhoek, A, Noor, N, Svrcek, M, Villanacci, V, Zidar, N & Tripathi, M 2022, ' ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease ', Journal of Crohn's & colitis, vol. 16, no. 3, pp. 343-368 . https://doi.org/10.1093/ecco-jcc/jjab141
Introduction Many diseases can imitate inflammatory bowel disease [IBD] clinically and pathologically. This review outlines the differential diagnosis of IBD and discusses morphological pointers and ancillary techniques that assist with the distincti
Autor:
Michail Doukas, Merel van Pieterson, Sarah T A Teklenburg-Roord, Herbert M. van Wering, Lissy de Ridder, Dimitris Rizopoulos, Martinus A. Cozijnsen, Maria M E Jongsma, Obbe F. Norbruis, Michiel P. van Wijk, Marco W.J. Schreurs, Thalia Hummel, Johanna C. Escher, Janneke M. Stapelbroek, Michael Groeneweg, Kaija-Leena Kolho, Cathelijne van der Feen, Iva Hojsak, Tim G. J. de Meij, Janneke N. Samsom, M Aardoom, Victorien M. Wolters, Patrick F. van Rheenen
Publikováno v:
Jongsma, M M E, Aardoom, M A, Cozijnsen, M A, van Pieterson, M, de Meij, T, Groeneweg, M, Norbruis, O F, Wolters, V M, van Wering, H M, Hojsak, I, Kolho, K-L, Hummel, T, Stapelbroek, J, van der Feen, C, van Rheenen, P F, van Wijk, M P, Teklenburg-Roord, S T A, Schreurs, M W J, Rizopoulos, D, Doukas, M, Escher, J C, Samsom, J N & de Ridder, L 2022, ' First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: An open-label multicentre randomised controlled trial ', Gut, vol. 71, no. 1, pp. 34-42 . https://doi.org/10.1136/gutjnl-2020-322339
Gut, 71(1), 34-42. BMJ Publishing Group
Gut, 71, 34-42. BMJ PUBLISHING GROUP
Gut, 71(1), 34-42. BMJ Publishing Group
Gut, 71, 34-42. BMJ PUBLISHING GROUP
ObjectiveIn newly diagnosed paediatric patients with moderate-to-severe Crohn’s disease (CD), infliximab (IFX) is initiated once exclusive enteral nutrition (EEN), corticosteroid and immunomodulator therapies have failed. We aimed to investigate wh
Autor:
Peter C. Church, Jeffrey Hyams, Frank Ruemmele, Lissy de Ridder, Dan Turner, Anne M. Griffiths
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Background and Aims. Use of anti-TNF therapies varies internationally. As an initiative of the international Pediatric IBD Network (PIBDNet), we compared global pediatric IBD anti-TNF practice patterns. Methods. Physicians were surveyed about anti-TN
Externí odkaz:
https://doaj.org/article/c3d2a16181e14e7183c99349220322c8
Autor:
Stephanie A. Vuijk, Lissy de Ridder
Publikováno v:
Alimentary Pharmacology and Therapeutics, 57(5), 565-566. Wiley-Blackwell Publishing Ltd